sábado, 28 de diciembre de 2019

Crash and burn: The four biggest biopharma failures of 2019 - STAT

Crash and burn: The four biggest biopharma failures of 2019 - STAT

Daily Recap

STAT Plus: Crash and burn: The four biggest biopharma failures of 2019

By KATE SHERIDAN


ALEX HOGAN/STAT
We looked back at the four most significant biopharma blowups of the year — and the consequences they had for patients, investors and employees.

No hay comentarios: